BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 29087473)

  • 1. Topical 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibition Corrects Cutaneous Features of Systemic Glucocorticoid Excess in Female Mice.
    Tiganescu A; Hupe M; Uchida Y; Mauro T; Elias PM; Holleran WM
    Endocrinology; 2018 Jan; 159(1):547-556. PubMed ID: 29087473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased glucocorticoid activation during mouse skin wound healing.
    Tiganescu A; Hupe M; Uchida Y; Mauro T; Elias PM; Holleran WM
    J Endocrinol; 2014 Apr; 221(1):51-61. PubMed ID: 24464022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbenoxolone treatment ameliorated metabolic syndrome in WNIN/Ob obese rats, but induced severe fat loss and glucose intolerance in lean rats.
    Prasad Sakamuri SS; Sukapaka M; Prathipati VK; Nemani H; Putcha UK; Pothana S; Koppala SR; Ponday LR; Acharya V; Veetill GN; Ayyalasomayajula V
    PLoS One; 2012; 7(12):e50216. PubMed ID: 23284633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 11β-Hydroxysteroid dehydrogenase blockade prevents age-induced skin structure and function defects.
    Tiganescu A; Tahrani AA; Morgan SA; Otranto M; Desmoulière A; Abrahams L; Hassan-Smith Z; Walker EA; Rabbitt EH; Cooper MS; Amrein K; Lavery GG; Stewart PM
    J Clin Invest; 2013 Jul; 123(7):3051-60. PubMed ID: 23722901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral 11β-HSD1 inhibitor AZD4017 improves wound healing and skin integrity in adults with type 2 diabetes mellitus: a pilot randomized controlled trial.
    Ajjan RA; Hensor EMA; Del Galdo F; Shams K; Abbas A; Fairclough RJ; Webber L; Pegg L; Freeman A; Taylor AE; Arlt W; Morgan AW; Tahrani AA; Stewart PM; Russell DA; Tiganescu A
    Eur J Endocrinol; 2022 Feb; 186(4):441-455. PubMed ID: 35113805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of 11β-hydroxysteroid dehydrogenase 1 by carbenoxolone affects glucose homeostasis and obesity in db/db mice.
    Dhanesha N; Joharapurkar A; Shah G; Kshirsagar S; Dhote V; Sharma A; Jain M
    Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):69-77. PubMed ID: 22060140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sub-chronic administration of the 11beta-HSD1 inhibitor, carbenoxolone, improves glucose tolerance and insulin sensitivity in mice with diet-induced obesity.
    Taylor A; Irwin N; McKillop AM; Flatt PR; Gault VA
    Biol Chem; 2008 Apr; 389(4):441-5. PubMed ID: 18225986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local cortisol/corticosterone activation in skin physiology and pathology.
    Terao M; Katayama I
    J Dermatol Sci; 2016 Oct; 84(1):11-16. PubMed ID: 27431412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreases lipolysis.
    Tomlinson JW; Sherlock M; Hughes B; Hughes SV; Kilvington F; Bartlett W; Courtney R; Rejto P; Carley W; Stewart PM
    J Clin Endocrinol Metab; 2007 Mar; 92(3):857-64. PubMed ID: 17200165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 11β-Hydroxysteroid dehydrogenase-1 is a novel regulator of skin homeostasis and a candidate target for promoting tissue repair.
    Terao M; Murota H; Kimura A; Kato A; Ishikawa A; Igawa K; Miyoshi E; Katayama I
    PLoS One; 2011; 6(9):e25039. PubMed ID: 21949844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbenoxolone prevents chemical eye ischemia-reperfusion-induced cell death via 11β-hydroxysteroid dehydrogenase type 1 inhibition.
    Choi KJ; Na YJ; Park SB; Jung WH; Sung HR; Kim KY
    Pharmacol Res; 2017 Sep; 123():62-72. PubMed ID: 28687341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Expression of 11β-Hydroxysteroid Dehydrogenase Type 1 Contributes to Epidermal Permeability Barrier Dysfunction in Aged Skin.
    Kim BJ; Lee NR; Lee CH; Lee YB; Choe SJ; Lee S; Hwang HJ; Kim E; Lavery GG; Shin KO; Park K; Choi EH
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of 11β-hydroxysteroid dehydrogenase type 1 in the development of atopic dermatitis.
    Lee NR; Kim BJ; Lee CH; Lee YB; Lee S; Hwang HJ; Kim E; Kim SH; Lee MG; Lee SE; Lavery GG; Choi EH
    Sci Rep; 2020 Nov; 10(1):20237. PubMed ID: 33214595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of carbenoxolone, an 11β-HSD1 inhibitor, against chemical induced dry eye syndrome.
    Na YJ; Choi KJ; Park SB; Sung HR; Jung WH; Kim HY; Rhee SD; Kim KY
    Apoptosis; 2017 Nov; 22(11):1441-1453. PubMed ID: 28887719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UVB induces epidermal 11β-hydroxysteroid dehydrogenase type 1 activity in vivo.
    Tiganescu A; Hupe M; Jiang YJ; Celli A; Uchida Y; Mauro TM; Bikle DD; Elias PM; Holleran WM
    Exp Dermatol; 2015 May; 24(5):370-6. PubMed ID: 25739654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo evaluation of 11beta-hydroxysteroid dehydrogenase activity in the rabbit eye.
    Anderson S; Carreiro S; Quenzer T; Gale D; Xiang C; Gukasyan H; Lafontaine J; Cheng H; Krauss A; Prasanna G
    J Ocul Pharmacol Ther; 2009 Jun; 25(3):215-22. PubMed ID: 19456256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 11β-Hydroxysteroid dehydrogenase type 1 shRNA ameliorates glucocorticoid-induced insulin resistance and lipolysis in mouse abdominal adipose tissue.
    Wang Y; Yan C; Liu L; Wang W; Du H; Fan W; Lutfy K; Jiang M; Friedman TC; Liu Y
    Am J Physiol Endocrinol Metab; 2015 Jan; 308(1):E84-95. PubMed ID: 25389364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of hepatic glucocorticoid receptor and hexose-6-phosphate dehydrogenase expression ameliorates diet-induced obesity and insulin resistance in mice.
    Liu Y; Nakagawa Y; Wang Y; Liu L; Du H; Wang W; Ren X; Lutfy K; Friedman TC
    J Mol Endocrinol; 2008 Aug; 41(2):53-64. PubMed ID: 18524870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 11beta-hydroxysteroid dehydrogenase type 1 and obesity.
    Morton NM; Seckl JR
    Front Horm Res; 2008; 36():146-164. PubMed ID: 18230901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 11β-hydroxysteroid dehydrogenase 1 specific inhibitor increased dermal collagen content and promotes fibroblast proliferation.
    Terao M; Tani M; Itoi S; Yoshimura T; Hamasaki T; Murota H; Katayama I
    PLoS One; 2014; 9(3):e93051. PubMed ID: 24667799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.